Nutex Health (NUTX) Gross Profit (2010 - 2026)

Nutex Health (NUTX) has 17 years of Gross Profit data on file, last reported at $91.7 million in Q1 2026.

• Quarterly Gross Profit fell 22.48% year-over-year to $91.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $417.7 million (up 37.19% YoY) and the FY2025 annual result came in at $444.3 million, up 126.37% from the prior year.
• Gross Profit climbed to $91.7 million in Q1 2026 per NUTX's latest filing, from $46.1 million in the prior quarter.
• The five-year high for Gross Profit was $154.9 million in Q3 2025, with the low at -$26.5 million in Q3 2022.
• Average Gross Profit over 5 years is $46.1 million, with a median of $21.9 million recorded in 2024.
• The widest YoY moves for Gross Profit: up 8290.22% in 2022, down 134.82% in 2022.
• Nutex Health's Gross Profit stood at $530324.0 in 2022, then jumped by 2391.55% to $13.2 million in 2023, then surged by 971.84% to $141.6 million in 2024, then slumped by 67.42% to $46.1 million in 2025, then soared by 98.82% to $91.7 million in 2026.
• Business Quant data shows NUTX's Gross Profit at $91.7 million in Q1 2026, $46.1 million in Q4 2025, and $154.9 million in Q3 2025.